Effect of Community Pharmacist-Led Dietary Salt Restriction Guidance on Salt Taste Sensitivity in Outpatients with Chronic Kidney Disease: A Pilot Study
Abstract
An increased salt taste sensitivity threshold may lead to high salt intake in patients with chronic kidney disease (CKD). The present study aimed to evaluate whether community pharmacist-led dietary salt restriction guidance improved salt taste sensitivity; its association with salt intake in outpatients with CKD was quantified. A multicenter, prospective, open-label, single-arm study was conducted with a before-and-after comparison design in six community pharmacies. Eligible patients (n = 14) with an estimated glomerular filtration rate <60 mL/min/1.73 m2 received salt restriction guidance from pharmacists, and a sodium-impregnated strip test, a tool for assessing salt taste sensitivity, was conducted in community pharmacies. Daily estimated salt intake was calculated from spot urine samples collected at the hospital. The primary outcome was the change in the threshold of taste recognition at 12 weeks post-intervention. The association between changes in the taste recognition threshold and estimated salt intake was evaluated using regression analysis. The median taste recognition threshold significantly decreased from 1.20 (interquartile range [IQR]: 0.80–1.35) to 1.00 (IQR: 0.80–1.00) (p = 0.033). Seventy-one percent of patients with a baseline threshold ≥0.8% showed improvement, with an effect size of −0.57. A greater reduction in the threshold was associated with a decreasing trend in the estimated salt intake. In conclusion, this pilot study suggests that community pharmacist-led dietary salt restriction guidance may improve salt taste recognition thresholds in outpatients with CKD. The sodium-impregnated strip test may be useful in promoting awareness of dietary salt restriction and in reflecting changes related to salt intake in community pharmacy settings.
Related
- Criterion‐Related Validity of the Couple Flourishing Measure in a Spanish Population: Distinguishing Outpatients From Community Participants
- Perspective: Do Fasting, Caloric Restriction, and Diets Increase Sensitivity to Radiotherapy? A Literature Review
- Building on the 2025 national academies pharmacy workshop: ensuring access to community pharmacist care.
- Pharmacist management of oral anticoagulation for atrial fibrillation in the community: The APOTHECARY AF study.
- Gambling Involvement And Gambling-Related Problem Severity Among Psychiatric Outpatients And Community Participants.
BibTeX
@article{asai2026effect,
title = {{Effect of Community Pharmacist-Led Dietary Salt Restriction Guidance on Salt Taste Sensitivity in Outpatients with Chronic Kidney Disease: A Pilot Study}},
author = {Yuki Asai and Tomohiro Murata and Asami Muramatsu and Shohei Fukagawa and Shun Miyaoka and Shinji Ushida and Hironari Hayashi and Koji Matsumoto and Shunsaku Okumura and Toshiki Murasaka and Chie Suezawa and Takuya Iwamoto},
journal = {Biological and Pharmaceutical Bulletin},
year = {2026},
month = jul,
doi = {10.1248/bpb.b26-00219},
url = {https://www.jstage.jst.go.jp/article/bpb/49/7/49_b26-00219/_article},
note = {CC BY-NC},
}
RIS
TY - JOUR
TI - Effect of Community Pharmacist-Led Dietary Salt Restriction Guidance on Salt Taste Sensitivity in Outpatients with Chronic Kidney Disease: A Pilot Study
AU - Yuki Asai
AU - Tomohiro Murata
AU - Asami Muramatsu
AU - Shohei Fukagawa
AU - Shun Miyaoka
AU - Shinji Ushida
AU - Hironari Hayashi
AU - Koji Matsumoto
AU - Shunsaku Okumura
AU - Toshiki Murasaka
AU - Chie Suezawa
AU - Takuya Iwamoto
PY - 2026
DA - 2026/07/24
JO - Biological and Pharmaceutical Bulletin
DO - 10.1248/bpb.b26-00219
UR - https://www.jstage.jst.go.jp/article/bpb/49/7/49_b26-00219/_article
AB - An increased salt taste sensitivity threshold may lead to high salt intake in patients with chronic kidney disease (CKD). The present study aimed to evaluate whether community pharmacist-led dietary salt restriction guidance improved salt taste sensitivity; its association with salt intake in outpatients with CKD was quantified. A multicenter, prospective, open-label, single-arm study was conducted with a before-and-after comparison design in six community pharmacies. Eligible patients (n = 14) with an estimated glomerular filtration rate <60 mL/min/1.73 m2 received salt restriction guidance from pharmacists, and a sodium-impregnated strip test, a tool for assessing salt taste sensitivity, was conducted in community pharmacies. Daily estimated salt intake was calculated from spot urine samples collected at the hospital. The primary outcome was the change in the threshold of taste recognition at 12 weeks post-intervention. The association between changes in the taste recognition threshold and estimated salt intake was evaluated using regression analysis. The median taste recognition threshold significantly decreased from 1.20 (interquartile range [IQR]: 0.80–1.35) to 1.00 (IQR: 0.80–1.00) (p = 0.033). Seventy-one percent of patients with a baseline threshold ≥0.8% showed improvement, with an effect size of −0.57. A greater reduction in the threshold was associated with a decreasing trend in the estimated salt intake. In conclusion, this pilot study suggests that community pharmacist-led dietary salt restriction guidance may improve salt taste recognition thresholds in outpatients with CKD. The sodium-impregnated strip test may be useful in promoting awareness of dietary salt restriction and in reflecting changes related to salt intake in community pharmacy settings.
SN - 1347-5215
SN - 0918-6158
ER -